• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>TSX

TSX

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Research
  1. Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks’ Azymetric™ Platform into Preclinical Development

    Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks’ Azymetric™ Platform into Preclinical Development

  2. PolyMet Reports Second Quarter Fiscal 2018 Results

    PolyMet Reports Second Quarter Fiscal 2018 Results

  3. Minnesota Releases Draft Dam Safety Permits for PolyMet Copper-Nickel Project

    Minnesota Releases Draft Dam Safety Permits for PolyMet Copper-Nickel Project

  4. TMAC Provides Operational Update and Results of Drilling

    TMAC Provides Operational Update and Results of Drilling

  5. Postmedia Network Canada Corp. Notice of Investors’ Teleconference

    Postmedia Network Canada Corp. Notice of Investors’ Teleconference

  6. Gold Reserve Provides September Venezuela Update

    Gold Reserve Provides September Venezuela Update

  7. SHAREHOLDER ALERT: Morganti Legal, P.C. Advises of Shareholder Investigation of Tahoe Resources, Inc.

    SHAREHOLDER ALERT: Morganti Legal, P.C. Advises of Shareholder Investigation of Tahoe Resources, Inc.

  8. Almonty Announces Debentureholders Holding Convertible Debentures in the Principal Amount of AUD$500,000 Have Elected to Convert into Common Shares at CAD$0.55 Per Common Share

    Almonty Announces Debentureholders Holding Convertible Debentures in the Principal Amount of AUD$500,000 Have Elected to Convert into Common Shares at CAD$0.55 Per Common Share

  9. VersaBank to Pay Quarterly Dividends on Series 1 & Series 3 Preferred Shares

    VersaBank to Pay Quarterly Dividends on Series 1 & Series 3 Preferred Shares

  10. biOasis Announces Formation of Scientific Advisory Board to Advance the Science for the Company’s Blood-Brain Barrier Drug Delivery Platform

    biOasis Announces Formation of Scientific Advisory Board to Advance the Science for the Company’s Blood-Brain Barrier Drug Delivery Platform

12345

©2017 Morningstar Advisor. All right reserved.